Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-DQ8 is a human leukocyte antigen (HLA) serotype within the HLA-DQ group, which is part of the major histocompatibility complex (MHC) class II molecules. It functions as a cell surface receptor involved in presenting peptides to T cells, playing a critical role in immune system regulation and adaptive immunity. It is strongly linked to several autoimmune diseases, including Celiac Disease, Type 1 Diabetes Mellitus, and Rheumatoid Arthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Leukocyte Antigen DQ8 (HLA-DQ8).